Frequency of Parasite Infection in Hyraxes and Sandflies During Outbreak of Leishmania Tropica Epidemic in The West Bank
NCT00737386 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600
Last updated 2011-08-16
Summary
The objective of the project is to study the pathogenesis of Leishmania tropica infection in a focus of infection, to learn about relationship of infection in humans with ecological factors such as infection in hyraxes reservoir hosts and vector sandflies
Conditions
- Cutaneous Leishmaniasis
Sponsors & Collaborators
-
Hadassah Medical Organization
lead OTHER
Eligibility
- Min Age
- 3 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-09-30
- Primary Completion
- 2011-12-31
- Completion
- 2011-12-31
Countries
- Israel
Study Locations
More Related Trials
-
Prospective Observational Study of Intralesional Treatment With Pentostam in Cutaneous Leishmaniasis Israeli Patients
NCT02281669 ·Status: UNKNOWN
-
ASYMPTOMATIC CARRIER OF LEISHMANIA INFANTUM, MEDISERRANEAN VISCERAL LEISHMANIOSIS AGENT: STUDY OF IMMUNE RESPONSE -
NCT03303898 ·Status: COMPLETED ·Phase: NA
-
Diagnosis and Treatment of Leishmania Infections
NCT00344188 ·Status: RECRUITING
-
Safety/Efficacy Trial of Killed Leishmania Vaccine in Volunteers With Positive Response to Leishmanin (LST>0)
NCT00429780 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Enhancing Protection Against Vector-borne Diseases in Forcibly Displaced Communities: Evaluating the Efficacy of Spatial Repellents for Cutaneous Leishmaniasis Control in North-East Syria
NCT06917040 ·Status: COMPLETED ·Phase: PHASE3
-
Liposomal Amphotericin in Disseminated Leishmaniasis
NCT02025491 ·Status: COMPLETED ·Phase: PHASE3
-
Spatial Analysis of Host-parasite Interactions in Cutaneous Leishmaniasis in Ethiopia
NCT05332093 ·Status: COMPLETED
-
Clinical Investigation of Infections Due to Leishmanial Parasites
NCT00001169 ·Status: COMPLETED
-
Mediterranean Visceral Leishmaniasis With Leishmania Infantum
NCT03784248 ·Status: ACTIVE_NOT_RECRUITING
-
Safety/Efficacy Trial of Killed Leishmania Vaccine in Volunteers With no Response to Leishmanin
NCT00429715 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study of the Efficacy and Safety of the LEISH-F2 + MPL-SE Vaccine for Treatment of Cutaneous Leishmaniasis
NCT01011309 ·Status: COMPLETED ·Phase: PHASE2
-
Local Heat Therapy Versus Sodium Stibogluconate for the Treatment of Cutaneous Leishmaniasis
NCT00884377 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Safety, Efficacy and Immunogenicity of Leishmania Vaccine ChAd63-KH in PKDL
NCT03969134 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Radio-frequency Induced Heat (RFH)Therapy in Treatment of Cutaneous Leishmaniasis in India
NCT01661296 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess Safety and Efficacy of a Leishmania Vaccine to Prevent Post Kala Azar Dermal Leishmaniasis (PKDL)
NCT04107961 ·Status: WITHDRAWN ·Phase: PHASE2
-
Study to Evaluate the Leish-111f + MPL-SE Vaccine in Healthy Adults Not Previously Exposed to Leishmania Parasite
NCT00121862 ·Status: COMPLETED ·Phase: PHASE2
-
Topical Liposomal Amphotericin B Gel Treatment for Cutaneous Leishmaniasis
NCT02656797 ·Status: COMPLETED ·Phase: PHASE2
-
Antihelminthic Therapy Combined With Antimony in the Treatment of Cutaneous Leishmaniasis
NCT00469495 ·Status: COMPLETED ·Phase: NA
-
Short Course of Miltefosine and Antimony to Treat Cutaneous Leishmaniasis in Bolivia
NCT00537953 ·Status: UNKNOWN ·Phase: PHASE2
-
SCH708980 With and Without AmBisome for Visceral Leishmaniasis
NCT01437020 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Intralesional Injection of Levofloxacin for the Management of Cutaneous Leishmaniasis
NCT06797544 ·Status: RECRUITING ·Phase: PHASE2
-
Intralesional Injection of Metronidazole for the Management of Cutaneous Leishmaniasis
NCT06798415 ·Status: RECRUITING ·Phase: PHASE2
-
Epidemiology of Cutaneous Leishmaniasis in Niger, Mali, Togo : Mapping of Clinical Cases, Species, Reservoirs and Vectors of the Disease
NCT06692985 ·Status: COMPLETED
-
LAMP Assay for the Diagnosis of Visceral Leishmaniasis
NCT04003532 ·Status: COMPLETED
-
Open-Label, Sequential Step, Safety and Efficacy Study to Determine the Optimal Single Dose of Ambisome for Patients With VL
NCT00832208 ·Status: TERMINATED ·Phase: PHASE2